FdaApplication
ANDA 212366
Identifiers
- fda_app_no: ANDA212366
Properties
| Property | Value |
|---|---|
| applicant_name | ALKEM LABS LTD |
| application_type | ANDA |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EMPAGLIFLOZIN; LINAGLIPTIN | EMPAGLIFLOZIN; LINAGLIPTIN | 25MG/5MG | TABLET;ORAL |
| EMPAGLIFLOZIN; LINAGLIPTIN | EMPAGLIFLOZIN; LINAGLIPTIN | 10MG/5MG | TABLET;ORAL |
2 products